Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 169

1.

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A, et al.

Science. 1989 May 12;244(4905):707-12.

PMID:
2470152
[PubMed - indexed for MEDLINE]
2.

Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.

Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R, et al.

Cancer Res. 1993 Oct 15;53(20):4960-70.

PMID:
8104689
[PubMed - indexed for MEDLINE]
Free Article
3.

HER-2/neu amplification and overexpression in primary human breast cancer is associated with early metastasis.

Tiwari RK, Borgen PI, Wong GY, Cordon-Cardo C, Osborne MP.

Anticancer Res. 1992 Mar-Apr;12(2):419-25.

PMID:
1349794
[PubMed - indexed for MEDLINE]
4.

HER-2/neu oncogene protein and prognosis in breast cancer.

Tandon AK, Clark GM, Chamness GC, Ullrich A, McGuire WL.

J Clin Oncol. 1989 Aug;7(8):1120-8.

PMID:
2569032
[PubMed - indexed for MEDLINE]
5.

HER-2/neu amplification predicts poor survival in node-positive breast cancer.

Borg A, Tandon AK, Sigurdsson H, Clark GM, Fernö M, Fuqua SA, Killander D, McGuire WL.

Cancer Res. 1990 Jul 15;50(14):4332-7.

PMID:
1973070
[PubMed - indexed for MEDLINE]
Free Article
6.

Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation.

Kury FD, Schneeberger C, Sliutz G, Kubista E, Salzer H, Medl M, Leodolter S, Swoboda H, Zeillinger R, Spona J.

Oncogene. 1990 Sep;5(9):1403-8.

PMID:
1699198
[PubMed - indexed for MEDLINE]
7.

Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.

Naber SP, Tsutsumi Y, Yin S, Zolnay SA, Mobtaker H, Marks PJ, McKenzie SJ, DeLellis RA, Wolfe HJ.

Am J Clin Pathol. 1990 Aug;94(2):125-36.

PMID:
1973590
[PubMed - indexed for MEDLINE]
8.

Identification of differentially expressed genes associated with HER-2/neu overexpression in human breast cancer cells.

Oh JJ, Grosshans DR, Wong SG, Slamon DJ.

Nucleic Acids Res. 1999 Oct 15;27(20):4008-17.

PMID:
10497265
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Overexpression of p185 is not related to erbB2 amplification in ovarian cancer.

Morali F, Cattabeni M, Tagliabue E, Campiglio M, Menard S, Marzola M, Lucchini V, Colombo N, Mangioni C, Redaelli L, et al.

Ann Oncol. 1993 Nov;4(9):775-9.

PMID:
7904177
[PubMed - indexed for MEDLINE]
10.

The role of the HER-2/neu oncogene in gynecologic cancers.

Cirisano FD, Karlan BY.

J Soc Gynecol Investig. 1996 May-Jun;3(3):99-105. Review.

PMID:
8796816
[PubMed - indexed for MEDLINE]
11.

Aberrant expression of the c-erbB-2/neu protooncogene in ovarian cancer.

Hung MC, Zhang X, Yan DH, Zhang HZ, He GP, Zhang TQ, Shi DR.

Cancer Lett. 1992 Jan 10;61(2):95-103.

PMID:
1346099
[PubMed - indexed for MEDLINE]
12.

Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.

Guérin M, Barrois M, Terrier MJ, Spielmann M, Riou G.

Oncogene Res. 1988;3(1):21-31.

PMID:
2905033
[PubMed - indexed for MEDLINE]
13.

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.

Press MF, Bernstein L, Thomas PA, Meisner LF, Zhou JY, Ma Y, Hung G, Robinson RA, Harris C, El-Naggar A, Slamon DJ, Phillips RN, Ross JS, Wolman SR, Flom KJ.

J Clin Oncol. 1997 Aug;15(8):2894-904.

PMID:
9256133
[PubMed - indexed for MEDLINE]
14.

HER-2/neu oncogene expression and proliferation in breast cancers.

Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW.

Am J Pathol. 1990 Jul;137(1):103-11.

PMID:
1973597
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.

Knyazev PG, Imyanitov EN, Chernitca OI, Nikiforova IF, Hanson KP.

Oncology. 1992;49(2):162-5.

PMID:
1349430
[PubMed - indexed for MEDLINE]
16.

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL.

Science. 1987 Jan 9;235(4785):177-82.

PMID:
3798106
[PubMed - indexed for MEDLINE]
17.

Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells.

Pietras RJ, Fendly BM, Chazin VR, Pegram MD, Howell SB, Slamon DJ.

Oncogene. 1994 Jul;9(7):1829-38.

PMID:
7911565
[PubMed - indexed for MEDLINE]
18.

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.

Pauletti G, Godolphin W, Press MF, Slamon DJ.

Oncogene. 1996 Jul 4;13(1):63-72.

PMID:
8700555
[PubMed - indexed for MEDLINE]
19.

Assessment of c-erbB-2 amplification by immunohistochemistry in paraffin-embedded breast cancer.

Kerns BJ, Jordan PA, Huper G, Marks JR, Iglehart JD, Layfied LJ.

Mod Pathol. 1993 Nov;6(6):673-8.

PMID:
7905629
[PubMed - indexed for MEDLINE]
20.

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.

Ross JS, Fletcher JA.

Stem Cells. 1998;16(6):413-28. Review.

PMID:
9831867
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk